Prism Medico and Pharmacy (BSE: PRISMMEDI) is loss-making over the last 12 months, losing ₹0.40 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹34.39. Sales grew 24% a year over 3 years. It is a small-cap company with a market cap of ₹47 Cr, ranked 51st of 81 Farm Products companies by market cap; the shares rose 86% over the past year.
- ₹36.50
- ₹37.88
- ₹34.00
- ₹35.51
- 2.9K
Health check
- ReturnsAhead
+86.2% over a year, better than 6 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +24.3% a year over 3 years, but loss-making now.
- ProfitabilityWeak
ROCE 2.6% vs peer median 10.6%.
- Balance sheetFair
Piotroski 7 of 9.
- Red flags3 to check
Loss-making over the last twelve months.
Small cap
Defensive
Key metrics
- Market cap
- ₹47 Cr
- Small cap
- P/E
- n/a
- Industry 13.7
- Price to book
- 1.35
- Peers 1.92
- Dividend yield
- 0.00%
- ROE
- 2.1%
- Peers 7.6%
- ROCE
- 2.6%
- Peers 10.6%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- −₹0.07
- OPM (TTM)
- −32.5%
- Net margin −46.5%
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- −108.9%
- Latest quarter vs a year ago
- Price to sales
- 54.57
- EV/EBITDA −182.5
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at 2.1%.
- Quarterly profit down 108.9% on a year ago.
About Prism Medico and Pharmacy
Prism Medico and Pharmacy Limited engages in the sale of pharmaceutical products in India. The company was formerly known as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January 2012. The company was incorporated in 1985 and is based in Sirmaur, India.
- Headquarters
- Sirmaur
- Sector
- Consumer Defensive
- ISIN
- INE730E01016
- Website
- prismmedico.in
Price range
- Avg volume (3M)
- 11K
- 1-year return
- plus 86.2%
- From 52-week high
- minus 9.2%
Peers · Farm Products
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AEROPLANEAmir Chand Jagdish Kumar (Exports) | 238.71 | minus 1.56% | 2,472 | 19.9 | 2.49 | 23.2% | 15.9% | 10.5% | 20.6% | 80.7% | 0.00% | plus 32.6% |
| VENKEYSVenky's (India) | 1,587.90 | minus 1.21% | 2,237 | 12.9 | 1.40 | 12.1% | 9.1% | 6.0% | −4.0% | 25.5% | 0.63% | plus 4.5% |
| ANDREWYUAndrew Yule & Company | 23.47 | minus 2.21% | 1,148 | – | 3.55 | −4.7% | −5.8% | −27.2% | −7.7% | – | 0.00% | minus 25.1% |
| PERVASIVEPervasive Commodities | 12.32 | minus 1.44% | 1,110 | – | – | 0.0% | −0.1% | −0.9% | – | – | 0.00% | plus 941.7% |
| APEXApex Frozen Foods | 324.45 | minus 1.14% | 1,014 | 19.7 | 1.92 | 10.6% | 7.6% | 7.7% | −4.5% | 2.7% | 0.77% | plus 39.0% |
| ZEALZeal Global Services | 69.45 | plus 4.99% | 876 | – | – | 33.8% | 14.7% | 4.0% | 22.5% | 26.0% | – | minus 39.9% |
| DBOLDhampur Bio Organics | 127.32 | minus 6.27% | 835 | 25.3 | 0.82 | 7.7% | 2.5% | 6.5% | −4.3% | −39.0% | 1.18% | plus 73.0% |
| PRISMMEDIPrism Medico and Pharmacy | 34.39 | minus 3.15% | 47 | – | 1.35 | 2.6% | 2.1% | −32.5% | 24.3% | – | 0.00% | plus 86.2% |
| Median of 7 peers | – | −1.44% | 1,110 | 19.8 | 1.92 | 10.6% | 7.6% | 6.0% | −4.2% | 25.5% | 0.32% | 32.6% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 1.6 | 0.5 | 0.1 | 0.3 | – | |
| 0.9 | 0.6 | 0.1 | 0.4 | – | |
| 0.7 | −0.1 | −0 | −0.1 | −0.1 | |
| 41.0% | −19.5% | −27.5% | −44.1% | – | |
| 0 | 0 | 0 | 0 | 0.1 | |
| – | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | |
| 0.7 | −0.1 | −0 | −0.1 | −0.1 | |
| −1.0% | – | – | −95.9% | – | |
| 0.7 | −0.1 | −0 | −0.2 | −0.1 | |
| 0.01 | -0.00 | -0.02 | -0.00 | -0.04 |
Profit & loss
- Sales CAGR 3Y
- +24.3%
- ROE
- 2.1%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.3 | 2.9 | 0.6 | 2.4 | |
| – | +130.2% | minus 78.4% | +286.7% | |
| 1.4 | 3.1 | 0.7 | 2 | |
| −0.1 | −0.1 | −0.1 | 0.4 | |
| −7.6% | −4.7% | −12.1% | 16.8% | |
| 0 | 0.1 | 0 | 0 | |
| 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | |
| – | 0 | – | – | |
| −0.1 | −0 | −0.1 | 0.4 | |
| 25.3% | 23.6% | 26.0% | 25.9% | |
| −0.1 | −0 | −0 | 0.3 | |
| -0.13 | -0.05 | -0.08 | 0.53 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 6.1 | 6.1 | 6.1 | 6.1 | |
| 9.1 | 9.1 | 9 | 9.3 | |
| 0.2 | 0.1 | 0.5 | 0.2 | |
| 15.4 | 15.2 | 15.6 | 15.6 | |
| 0 | 0 | 0 | 0 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 15.3 | 15.1 | 15.5 | 15.5 | |
| 15.4 | 15.2 | 15.6 | 15.6 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3 | −0 | −0 | 0 | |
| −2.9 | – | – | – | |
| −0 | −0 | −0 | −0 | |
| 0 | −0 | −0 | −0 | |
| 3 | −0 | −0 | 0 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.